The Consortium of Multiple Sclerosis Centers Annual Meeting is the leading research and educational conference for multiple sclerosis healthcare professionals of all disciplines in North America.
Discussing COVID-19 Vaccinations and Disease-Modifying Therapies in Multiple Sclerosis
November 4th 2021Amit Bar-Or, MD, FRCPC, FAAN, FANA, commented on his presentations at CMSC 2021, one of which focused on COVID-19 vaccination, which experts do not believe poses risks for those on disease-modifying therapies.
Talking Transitional Readiness for Teens With Multiple Sclerosis: Vikram Bhise, MD
November 3rd 2021The associate professor of pediatrics and neurology at Rutgers–Robert Wood Johnson Medical School commented on the need to recognize when adolescent patients are ready to learn more about their condition. [WATCH TIME: 5 minutes]
Transition Readiness, Quality of Life in Pediatric Multiple Sclerosis: Vikram Bhise, MD
October 29th 2021The associate professor of pediatrics and neurology at Rutgers–Robert Wood Johnson Medical School discussed findings from a qualitative study that aimed at understanding priorities and concerns within this patient population during a transitional period.
Diet and Comorbidities in Multiple Sclerosis: Mona Bostick, RDN, LDN, MSCS
October 29th 2021The registered dietitian at Food Matters 365 in Greensboro, North Carolina, discussed the role nutrition can play in treating comorbidities, sharing her thoughts on popular elimination diets. [WATCH TIME: 2 minutes]
Addressing and Assessing Fatigue in MS From a Multidisciplinary Approach
October 29th 2021Anna Kratz, PhD, associate professor of Physical Medicine & Rehabilitation, and a research nonclinical psychologist, University of Michigan Medicine, offered insight into the multidisciplinary approach to managing fatigue for patients with multiple sclerosis.
Promising Neuroimaging Biomarkers for Multiple Sclerosis: David Li, MD, FRCPC
October 27th 2021The director of the Multiple Sclerosis/MRI Research Group at the University of British Columbia spoke to some of the newer biomarkers and measures being assessed in the clinical management of multiple sclerosis. [WATCH TIME: 3 minutes]
Multiple Sclerosis MRI Protocol Card: David Li, MD, FRCPC
October 26th 2021The director of the Multiple Sclerosis/MRI Research Group at the University of British Columbia spoke to the portable Standardized MRI Protocol card that is being distributed in an effort to better inform the community to follow the newly published guidelines. [WATCH TIME: 2 minutes]
Induction vs Escalation for MS: Should Patients Be Started on High-Efficacy DMT?
October 26th 2021In the presidential lecture series at CMSC 2021, Ellen M. Mowry, MD, called into question whether or not the induction treatment approach in multiple sclerosis does in fact present a higher chance of preventing long-term disability.
The Long-Term Impact of Addressing Gender Norms for Men With MS
June 18th 2020In Part 2 of this interview, Bryan Davis, PsyD, MS, clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS, details the impact that conversations about masculinity norms in MS can have on future trials and care.
Bryan Davis, PsyD, MS: Future Discussion on Masculinity Norms in MS
June 16th 2020The clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research at Cleveland Clinic details the interventions for men with MS and how the study can change the discussion on masculinity norms.